https://ir.alzamend.com/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/alzamend/files/theme/images/logo-sm.png Equisolve Investor Relations Suite https://ir.alzamend.com/news-events/press-releases/detail/97/alzamend-neuro-announces-completion-of-clinical-portion-of Wed, 19 Nov 25 08:00:00 -0500 https://ir.alzamend.com/news-events/press-releases/detail/97/alzamend-neuro-announces-completion-of-clinical-portion-of https://ir.alzamend.com/news-events/press-releases/detail/96/alzamend-neuro-to-present-at-the-2025-military-health Mon, 28 Jul 25 08:00:00 -0400 https://ir.alzamend.com/news-events/press-releases/detail/96/alzamend-neuro-to-present-at-the-2025-military-health https://ir.alzamend.com/news-events/press-releases/detail/95/alzamend-neuro-reports-annual-2025-financial-results-and Wed, 23 Jul 25 08:00:00 -0400 https://ir.alzamend.com/news-events/press-releases/detail/95/alzamend-neuro-reports-annual-2025-financial-results-and https://ir.alzamend.com/news-events/press-releases/detail/94/alzamend-neuro-announces-final-closing-of-5-million Mon, 16 Jun 25 08:00:00 -0400 https://ir.alzamend.com/news-events/press-releases/detail/94/alzamend-neuro-announces-final-closing-of-5-million https://ir.alzamend.com/news-events/press-releases/detail/93/alzamend-neuro-announces-dosing-of-first-patient-in-its Thu, 29 May 25 08:00:00 -0400 https://ir.alzamend.com/news-events/press-releases/detail/93/alzamend-neuro-announces-dosing-of-first-patient-in-its https://ir.alzamend.com/news-events/press-releases/detail/92/alzamend-neuro-enrolls-first-patient-in-its-phase-ii Mon, 19 May 25 08:00:00 -0400 https://ir.alzamend.com/news-events/press-releases/detail/92/alzamend-neuro-enrolls-first-patient-in-its-phase-ii https://ir.alzamend.com/news-events/press-releases/detail/91/alzamend-neuro-initiates-first-phase-ii-clinical-trial-of Tue, 13 May 25 08:00:00 -0400 https://ir.alzamend.com/news-events/press-releases/detail/91/alzamend-neuro-initiates-first-phase-ii-clinical-trial-of https://ir.alzamend.com/news-events/press-releases/detail/90/alzamend-neuro-announces-reverse-stock-split Thu, 08 May 25 08:00:00 -0400 https://ir.alzamend.com/news-events/press-releases/detail/90/alzamend-neuro-announces-reverse-stock-split https://ir.alzamend.com/news-events/press-releases/detail/89/alzamend-neuro-partners-with-qmenta-to-advance-ai-powered Wed, 07 May 25 08:00:00 -0400 https://ir.alzamend.com/news-events/press-releases/detail/89/alzamend-neuro-partners-with-qmenta-to-advance-ai-powered https://ir.alzamend.com/news-events/press-releases/detail/88/alzamend-neuro-announces-initiation-date-of-phase-ii Tue, 25 Mar 25 08:00:00 -0400 https://ir.alzamend.com/news-events/press-releases/detail/88/alzamend-neuro-announces-initiation-date-of-phase-ii